Bristol-Myers Squibb was founded in 1858 and has grown ... Around the same time, the prototype of the Squibb logo was designed. The logo represented product uniformity, purity, efficacy and ...

Bristol-Myers Squibb's financial position improved, it raised both its EPS guidance and revenue expectations, and Opdivo's ...

Plenge currently works at PhRMA Foundation, as Director and Bristol Myers Squibb Co., as Chief Research Officer, Head-Research & EVP from 2019. Dr. Plenge also formerly worked at Translate Bio, Inc., ...

Bristol-Myers Squibb Company's undervaluation offers over 20% upside potential despite headwinds. Click here to find out why ...

The stock's fall snapped a four-day winning streak.

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Bernstein 41 st Annual Strategic ...

Bristol Myers Squibb is juggling financial wins and market challenges while pushing its promising drug pipeline forward. The ...

Bristol Myers Squibb is making waves as a value stock darling, thanks to its low P/E and robust drug portfolio. The company ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body ...